Top Page
Micro-X Ltd.
(Sydney:MX1)
Micro-X Ltd. (MX1) vs. S&P 500 (SPY)
Micro-X Ltd. Business Overview & Revenue Model
Micro-X Ltd. Financial Statement Overview
| Breakdown | |||||
| TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 14.43M | 15.22M | 15.01M | 8.97M | 3.77M | 4.25M | Gross Profit |
| 6.19M | 5.74M | -7.11M | -12.33M | -12.96M | -7.69M | EBIT |
| 1.65M | -13.03M | -16.30M | -19.77M | -15.83M | -11.69M | EBITDA |
| -15.75M | -14.35M | -14.71M | -19.02M | -13.61M | -9.29M | Net Income Common Stockholders |
| -10.78M | -9.77M | -10.75M | -17.09M | -14.73M | -10.07M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 2.39M | 3.23M | 5.22M | 10.30M | 30.14M | 18.32M | Total Assets |
| 19.96M | 26.89M | 30.30M | 31.28M | 44.68M | 33.70M | Total Debt |
| 5.18M | 3.99M | 4.77M | 5.38M | 5.90M | 13.54M | Net Debt |
| 2.79M | 762.00K | -455.00K | -4.92M | -24.23M | -4.77M | Total Liabilities |
| 13.85M | 12.63M | 13.17M | 12.05M | 10.53M | 18.96M | Stockholders Equity |
| 6.10M | 14.26M | 17.13M | 19.22M | 34.15M | 14.74M |
| Cash Flow | Free Cash Flow | ||||
| -9.22M | -6.80M | -11.77M | -19.22M | -10.76M | -11.65M | Operating Cash Flow |
| -9.07M | -6.43M | -10.99M | -18.11M | -9.86M | -9.46M | Investing Cash Flow |
| -152.00K | -369.00K | -779.00K | -1.11M | -901.00K | -2.20M | Financing Cash Flow |
| 6.31M | 4.81M | 6.69M | -612.00K | 22.57M | 28.37M |
Micro-X Ltd. Technical Analysis
Micro-X Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | AU$17.93M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
53 Neutral | AU$163.34M | ― | -58.61% | ― | ― | -74.88% | |
52 Neutral | $5.21B | 3.49 | -43.30% | 2.83% | 14.70% | -0.24% | |
47 Neutral | AU$42.69M | ― | -135.33% | ― | -27.58% | 33.69% | |
46 Neutral | AU$18.72M | ― | -45.31% | ― | -28.80% | 32.87% | |
36 Underperform | $21.48M | ― | -467.81% | ― | -75.71% | -8.26% |
Micro-X Ltd. Corporate Events
Micro-X Ltd. announced a change in the director’s interest, with Patrick O’Brien acquiring 1,428,571 ordinary shares, increasing his total holdings to 10,287,591 shares. This acquisition was made through a company placement approved by shareholders, reflecting confidence in the company’s strategic direction and potential growth, which could impact stakeholders positively by enhancing market confidence.
Micro-X Ltd. announced a change in the director’s interest, with Ilona Meyer acquiring 357,143 ordinary shares through a company placement approved by shareholders. This acquisition increases Meyer’s total holdings to 567,961 fully paid ordinary shares, indicating a significant investment in the company’s future, potentially impacting its market positioning and stakeholder confidence.
Micro-X Ltd. announced a change in the director’s interest, with Jim McDowell acquiring 714,286 ordinary shares through the company’s placement approved at the Extraordinary General Meeting in April 2025. This acquisition increases McDowell’s indirect holding, indicating a vote of confidence in the company’s strategic direction and potential growth, which could positively impact stakeholders and market perception.
Micro-X Ltd. announced a change in the director’s interest, with Director Andrew Hartmann acquiring 357,143 fully paid ordinary shares valued at $25,000. This acquisition was part of a company placement approved by shareholders, potentially strengthening the director’s alignment with company interests and signaling confidence in Micro-X’s future growth.
Micro-X Ltd. has announced the quotation of 2,857,143 ordinary fully paid securities on the Australian Securities Exchange (ASX) with the code MX1, set to be issued on May 8, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially impacting its industry positioning and stakeholder interests.
Micro-X Ltd. held an Extraordinary General Meeting on April 16, 2025, where several resolutions regarding the ratification and approval of the issuance of placement shares were passed. These resolutions, which received overwhelming support, are part of the company’s strategic initiatives to strengthen its financial position and expand its market presence.
Micro-X Ltd. announced the cessation of 1,167,220 performance rights due to the lapse of conditional rights that were not satisfied. This cessation may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational performance and strategic execution.
Micro-X Ltd. announced the issuance of 8,836,524 fully paid ordinary shares, which will be quoted on the ASX. This move is part of previously announced transactions and could potentially strengthen the company’s financial position, enhancing its market presence and providing additional resources for growth and development.
Micro-X Ltd announced the completion of its Retail Entitlement Offer, raising approximately $0.62 million, contributing to a total of $6.4 million in new funds from various capital raising initiatives. This financial boost strengthens Micro-X’s balance sheet, supporting its strategic execution in commercial and development products within medical imaging, and highlights the significant shareholder support crucial for the company’s ongoing success.
Micro-X Ltd. has announced an Extraordinary General Meeting scheduled for April 16, 2025, to discuss resolutions related to a recent capital raising initiative. The company successfully raised $6.0 million through various placements, including a strategic partnership with Billion Prima Sdn Bhd and institutional placements, to strengthen its financial position and support future growth. The meeting will address the refreshment of the company’s placement capacity and the issuance of shares to related parties, reflecting a strategic move to bolster its market presence and operational capabilities.
Micro-X Ltd. has announced the closing of its Retail Entitlement Offer on 14 March 2025, allowing eligible shareholders to apply for new shares at a price of A$0.07 each. This offer, which includes a ‘top-up’ facility for additional shares, aims to strengthen the company’s financial position and support its ongoing projects in health and security markets. The outcome of this offer could significantly impact Micro-X’s operations and market positioning, providing capital for further development of their innovative x-ray products and expansion into new applications.
Micro-X Ltd. has announced a change in the interests of a substantial holder, Acorn Capital Limited, which acts as an investment manager for various superannuation funds, institutional investor portfolios, and unit trusts. The change in voting power reflects an increase in Acorn Capital’s relevant interest in Micro-X Ltd.’s voting securities from 9.29% to 10.85%, indicating a significant shift in shareholder dynamics.
Micro-X Ltd has successfully completed a $2.4 million strategic placement with Billion Prima Sdn Bhd, issuing 26,666,667 ordinary shares at a 15% premium to the last traded price. This investment will support Micro-X’s growth and development in the health and security sectors, with Billion Prima agreeing to hold the shares for at least 12 months, which may strengthen Micro-X’s market position and stakeholder confidence.
Micro-X Ltd. has announced the issuance of 26,666,667 ordinary fully paid securities, which are set to be quoted on the Australian Securities Exchange (ASX) on March 5, 2025. This move is part of a previously announced transaction and is expected to bolster the company’s financial position, potentially enhancing its market presence and operational capabilities.
Micro-X Ltd. has released its financial results and operational update for the half-year ending December 31, 2024. The announcement provides insights into the company’s performance and strategic direction, although specific financial details are not disclosed. This update is crucial for stakeholders to understand Micro-X’s market positioning and future prospects.
Micro-X Limited reported a significant decrease in revenue by 51.67% to $3.961 million for the half-year ending December 31, 2024, compared to the previous period. The company also experienced an increase in losses by 13.28% to $8.681 million. No dividends were declared during this period. The financial statements were reviewed by auditors, who highlighted a material uncertainty related to the company’s going concern, indicating potential challenges in sustaining operations.
Micro-X Ltd. has announced an update regarding its proposed issue of securities, specifically extending the closing date for the Retail Entitlement Offer. This move is part of an accelerated non-renounceable entitlement offer, which could impact the company’s financial strategy and market positioning by potentially increasing its capital base.
Micro-X Ltd. has announced an extension of the closing date for its Retail Entitlement Offer to March 14, 2025, allowing Eligible Shareholders in Australia and New Zealand more time to participate. This offer allows shareholders to apply for one new share for every ten shares held, with the option to apply for additional shares up to 400% of their entitlement. This extension may enhance shareholder participation and potentially strengthen Micro-X’s financial position, supporting its ongoing projects and expansion efforts in the health and security markets.
Micro-X Ltd. has announced a change in substantial holdings, as Perennial Value Management Limited’s voting power has increased from 11.69% to 12.90%. This change is attributed to a series of market transactions primarily involving HSBC, Citicorp Nominees Pty Limited, and Northern Trust, which have altered their interests in Micro-X’s securities. The issuance of new shares has increased the total shares on issue, impacting the company’s market dynamics. These developments are likely to influence Micro-X’s market positioning and shareholder structure.
Micro-X Limited has announced the issuance of 25,742,859 fully paid ordinary shares to sophisticated and professional investors at a price of $0.07 per share. This move is expected to strengthen the company’s financial position and support its ongoing expansion efforts, particularly in the United States. The announcement reflects Micro-X’s commitment to advancing its presence in global health and security markets through innovative technology and strategic partnerships, such as the collaboration with the US Department of Homeland Security for next-generation airport security checkpoints.
Micro-X Ltd announced the issuance of 44,950,106 new fully paid ordinary securities to be quoted on the Australian Securities Exchange under the code MX1, effective from February 18, 2025. This issuance is part of previously announced transactions and signifies an expansion in the company’s capital structure, potentially enhancing its market position and operational capacity.
Micro-X Ltd. announced an update to its previous proposal regarding the issue of securities, specifically changing the number of shares issued through placement. This update pertains to an accelerated non-renounceable entitlement offer, which is significant for stakeholders as it may influence the company’s capital structure and market position.
Micro-X Ltd has announced the distribution of its Retail Offer Booklet and Entitlement Forms, as part of a 1 for 10 accelerated non-renounceable entitlement offer. This move is significant for Micro-X as it aims to enhance its financial standing and expand its market presence, particularly in the US where it is rapidly growing its business. The company continues to innovate in the health and security sectors, with ongoing projects including collaborations with the US Department of Homeland Security and the Australian Government’s Medical Research Future Fund.
Micro-X Ltd has secured a $6.0 million contract extension from the U.S. Department of Homeland Security to continue its development of self-screening airport checkpoints. This extension funds the creation and testing of additional checkpoint units, marking progress towards airport testing with passengers, and underscores Micro-X’s industry positioning as a leader in advanced security and imaging technologies.
Micro-X Limited has announced a retail entitlement offer to raise approximately A$2.7 million by issuing new shares to eligible retail shareholders. The offer is managed by Hawkesbury Partners Pty Limited and Morgans Corporate Limited and aims to strengthen the company’s financial position, potentially impacting its operational capabilities and market stance.
Micro-X Ltd has announced the opening of its Retail Entitlement Offer, part of a $6.0 million capital raising initiative. This move includes a $2.0 million placement to institutional investors and a $4.0 million entitlement offer, with strategic support from Billion Prima Sdn Bhd. The Retail Entitlement Offer aims to raise $2.7 million, allowing eligible shareholders to purchase new shares at a price of A$0.07. This capital raising is set to enhance Micro-X’s financial position, supporting its ongoing projects and market expansion efforts.